Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.
Identifieur interne : 000005 ( PubMed/Curation ); précédent : 000004; suivant : 000006Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.
Auteurs : Xiaodong Wu [République populaire de Chine] ; Bo Fu [République populaire de Chine] ; Lang Chen [République populaire de Chine] ; Yong Feng [République populaire de Chine]Source :
- Journal of medical virology [ 1096-9071 ] ; 2020.
Abstract
The Wuhan City has ended the lockdown and people have been allowed to resume working since April 8 if meeting a set of COVID-19-associated tests including SARS-CoV-2 nucleic acid test (NAT) of nasopharyngeal swabs, chest CT scan or a SARS-CoV-2-specific serological test. Here, we reported the positive rate of COVID-19 tests based on NAT, chest CT scan and a serological SARS-CoV-2 test, from April 3 to 15 in one hospital in Qingshan Destrict, Wuhan. We observed a ~10% SARS-CoV-2-specific IgG positive rate from 1,402 tests. Combination of SARS-CoV-2 NAT and a specific serological test might facilitate the detection of COVID-19 infection, or the asymptomatic SARS-CoV-2-infected subjects. Large-scale investigation is required to evaluate the herd immunity of the city, for the resuming people and for the re-opened city. This article is protected by copyright. All rights reserved.
DOI: 10.1002/jmv.25904
PubMed: 32311142
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000005
Links to Exploration step
pubmed:32311142Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.</title>
<author><name sortKey="Wu, Xiaodong" sort="Wu, Xiaodong" uniqKey="Wu X" first="Xiaodong" last="Wu">Xiaodong Wu</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Respiratory and Critical Care Medicine, CR & WISCO General Hospital, Wuhan, 430080, Hubei, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Respiratory and Critical Care Medicine, CR & WISCO General Hospital, Wuhan, 430080, Hubei</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fu, Bo" sort="Fu, Bo" uniqKey="Fu B" first="Bo" last="Fu">Bo Fu</name>
<affiliation wicri:level="1"><nlm:affiliation>Dept. of Clinical Laboratory, CR & WISCO General Hospital, Wuhan, 430080, Hubei, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Dept. of Clinical Laboratory, CR & WISCO General Hospital, Wuhan, 430080, Hubei</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Chen, Lang" sort="Chen, Lang" uniqKey="Chen L" first="Lang" last="Chen">Lang Chen</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430071, Hubei, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430071, Hubei</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Feng, Yong" sort="Feng, Yong" uniqKey="Feng Y" first="Yong" last="Feng">Yong Feng</name>
<affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Virology/Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430071, Hubei, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Virology/Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430071, Hubei</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32311142</idno>
<idno type="pmid">32311142</idno>
<idno type="doi">10.1002/jmv.25904</idno>
<idno type="wicri:Area/PubMed/Corpus">000005</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000005</idno>
<idno type="wicri:Area/PubMed/Curation">000005</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000005</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.</title>
<author><name sortKey="Wu, Xiaodong" sort="Wu, Xiaodong" uniqKey="Wu X" first="Xiaodong" last="Wu">Xiaodong Wu</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Respiratory and Critical Care Medicine, CR & WISCO General Hospital, Wuhan, 430080, Hubei, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Respiratory and Critical Care Medicine, CR & WISCO General Hospital, Wuhan, 430080, Hubei</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fu, Bo" sort="Fu, Bo" uniqKey="Fu B" first="Bo" last="Fu">Bo Fu</name>
<affiliation wicri:level="1"><nlm:affiliation>Dept. of Clinical Laboratory, CR & WISCO General Hospital, Wuhan, 430080, Hubei, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Dept. of Clinical Laboratory, CR & WISCO General Hospital, Wuhan, 430080, Hubei</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Chen, Lang" sort="Chen, Lang" uniqKey="Chen L" first="Lang" last="Chen">Lang Chen</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430071, Hubei, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430071, Hubei</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Feng, Yong" sort="Feng, Yong" uniqKey="Feng Y" first="Yong" last="Feng">Yong Feng</name>
<affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Virology/Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430071, Hubei, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Virology/Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430071, Hubei</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of medical virology</title>
<idno type="eISSN">1096-9071</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The Wuhan City has ended the lockdown and people have been allowed to resume working since April 8 if meeting a set of COVID-19-associated tests including SARS-CoV-2 nucleic acid test (NAT) of nasopharyngeal swabs, chest CT scan or a SARS-CoV-2-specific serological test. Here, we reported the positive rate of COVID-19 tests based on NAT, chest CT scan and a serological SARS-CoV-2 test, from April 3 to 15 in one hospital in Qingshan Destrict, Wuhan. We observed a ~10% SARS-CoV-2-specific IgG positive rate from 1,402 tests. Combination of SARS-CoV-2 NAT and a specific serological test might facilitate the detection of COVID-19 infection, or the asymptomatic SARS-CoV-2-infected subjects. Large-scale investigation is required to evaluate the herd immunity of the city, for the resuming people and for the re-opened city. This article is protected by copyright. All rights reserved.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32311142</PMID>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Apr</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Journal of medical virology</Title>
<ISOAbbreviation>J. Med. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.25904</ELocationID>
<Abstract><AbstractText>The Wuhan City has ended the lockdown and people have been allowed to resume working since April 8 if meeting a set of COVID-19-associated tests including SARS-CoV-2 nucleic acid test (NAT) of nasopharyngeal swabs, chest CT scan or a SARS-CoV-2-specific serological test. Here, we reported the positive rate of COVID-19 tests based on NAT, chest CT scan and a serological SARS-CoV-2 test, from April 3 to 15 in one hospital in Qingshan Destrict, Wuhan. We observed a ~10% SARS-CoV-2-specific IgG positive rate from 1,402 tests. Combination of SARS-CoV-2 NAT and a specific serological test might facilitate the detection of COVID-19 infection, or the asymptomatic SARS-CoV-2-infected subjects. Large-scale investigation is required to evaluate the herd immunity of the city, for the resuming people and for the re-opened city. This article is protected by copyright. All rights reserved.</AbstractText>
<CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName>
<ForeName>Xiaodong</ForeName>
<Initials>X</Initials>
<AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, CR & WISCO General Hospital, Wuhan, 430080, Hubei, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fu</LastName>
<ForeName>Bo</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Dept. of Clinical Laboratory, CR & WISCO General Hospital, Wuhan, 430080, Hubei, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chen</LastName>
<ForeName>Lang</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430071, Hubei, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Feng</LastName>
<ForeName>Yong</ForeName>
<Initials>Y</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-1590-0186</Identifier>
<AffiliationInfo><Affiliation>State Key Laboratory of Virology/Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430071, Hubei, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Med Virol</MedlineTA>
<NlmUniqueID>7705876</NlmUniqueID>
<ISSNLinking>0146-6615</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronavirus < Virus classification</Keyword>
<Keyword MajorTopicYN="N">Humoral immunity < Immune responses</Keyword>
<Keyword MajorTopicYN="N">Inapparent infection < Epidemiology</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>4</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32311142</ArticleId>
<ArticleId IdType="doi">10.1002/jmv.25904</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000005 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000005 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:32311142 |texte= Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:32311142" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |